ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancerAnke Bill, L. Alex Gaither, Abraham Gutierrez et al.|Oncotarget|2015Cited by 110
Role of anoctamins in cancer and apoptosisPodchanart Wanitchakool, Karl Kunzelmann, Gudrun E. Koehl et al.|Philosophical Transactions of the Royal Society B Biological Sciences|2014Cited by 95
TMEM16A/ANO1 suppression improves response to antibody‐mediated targeted therapy of EGFR and HER2/ERBB2Sucheta Kulkarni, Umamaheswar Duvvuri, Anke Bill et al.|Genes Chromosomes and Cancer|2017Cited by 46
HER3 targeting potentiates growth suppressive effects of the PI3K inhibitor BYL719 in pre-clinical models of head and neck squamous cell carcinomaKara D. Meister, Umamaheswar Duvvuri, Neal R. Godse et al.|Scientific Reports|2019Cited by 19